X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (765) 765
Publication (92) 92
Patent (24) 24
Book Chapter (13) 13
Conference Proceeding (13) 13
Book Review (9) 9
Book / eBook (7) 7
Dissertation (3) 3
Newspaper Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (390) 390
index medicus (299) 299
oncology (236) 236
female (207) 207
male (202) 202
aged (172) 172
middle aged (167) 167
cancer (125) 125
adult (116) 116
chemotherapy (90) 90
metastasis (86) 86
treatment outcome (77) 77
care and treatment (76) 76
aged, 80 and over (73) 73
prognosis (73) 73
retrospective studies (73) 73
antineoplastic agents - therapeutic use (68) 68
survival (66) 66
animals (63) 63
analysis (54) 54
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
research (51) 51
pharmacology & pharmacy (49) 49
tumors (47) 47
colorectal cancer (46) 46
colorectal neoplasms - drug therapy (46) 46
therapy (45) 45
hematology, oncology and palliative medicine (42) 42
breast cancer (41) 41
metastases (41) 41
patients (40) 40
cetuximab (38) 38
bone neoplasms - secondary (37) 37
neoplasm metastasis (37) 37
zoledronic acid (37) 37
cell biology (36) 36
immunohistochemistry (36) 36
hematology (35) 35
expression (34) 34
medicine & public health (34) 34
risk factors (34) 34
survival analysis (34) 34
mutation (33) 33
surgery (32) 32
drug therapy (31) 31
antineoplastic agents - pharmacology (30) 30
cancer patients (30) 30
disease-free survival (30) 30
neoplasm staging (30) 30
settore med/06 - oncologia medica (30) 30
cardiac & cardiovascular systems (28) 28
medicine (28) 28
prospective studies (28) 28
antibodies, monoclonal - therapeutic use (27) 27
bisphosphonates (27) 27
cells (27) 27
diphosphonates - therapeutic use (27) 27
double-blind (27) 27
efficacy (27) 27
health aspects (27) 27
apoptosis (26) 26
neoplasms - drug therapy (26) 26
time factors (26) 26
antibodies, monoclonal, humanized (25) 25
bevacizumab (25) 25
bone neoplasms - drug therapy (25) 25
breast-cancer (25) 25
cancer therapies (25) 25
diagnosis (25) 25
research article (25) 25
bone metastases (24) 24
carcinoma (24) 24
management (24) 24
multidisciplinary sciences (24) 24
angiogenesis (23) 23
antineoplastic agents (23) 23
breast neoplasms - drug therapy (23) 23
cancer research (23) 23
clinical trials (23) 23
colorectal neoplasms - pathology (23) 23
disease (23) 23
italy (23) 23
multivariate analysis (23) 23
patient outcomes (23) 23
antineoplastic agents - adverse effects (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (22) 22
carcinoma, renal cell - drug therapy (22) 22
trial (22) 22
colorectal neoplasms - genetics (21) 21
medical research (21) 21
mortality (21) 21
risk (21) 21
sunitinib (21) 21
antimitotic agents (20) 20
biochemistry & molecular biology (20) 20
disease progression (20) 20
drug administration schedule (20) 20
medical prognosis (20) 20
prostate cancer (20) 20
targeted therapy (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (785) 785
Italian (20) 20
French (15) 15
Portuguese (8) 8
German (6) 6
Spanish (4) 4
Russian (2) 2
Slovenian (2) 2
Chinese (1) 1
Danish (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 9, pp. 888 - 889
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2015, Volume 5, Issue 1, p. 18670
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. TPS405 - TPS405
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 09/2012, Volume 16, Issue 9, pp. 2186 - 2195
Zoledronic acid (ZOL) is the most potent nitrogen‐containing bisphosphonate (N‐BPs) that strongly binds to bone mineral and acts as a powerful inhibitor of... 
FN1 | breast cancer | TGF‐β1 | invasion | ZOL | THBS‐1 | TGF-β1 | Breast cancer | THBS-1 | Invasion | MEDICINE, RESEARCH & EXPERIMENTAL | GROWTH-INHIBITION | TGF-BETA | CARCINOMA CELLS | NITROGEN-CONTAINING BISPHOSPHONATES | TGF-ss 1 | INDUCE APOPTOSIS | CELL BIOLOGY | IN-VITRO | CASTRATED RATS | SIGNALING PATHWAY | PROBE LEVEL | BONE METASTASIS | Up-Regulation | Cell Proliferation | Humans | Transforming Growth Factor beta1 - metabolism | Bone Resorption - drug therapy | Gene Expression Regulation, Neoplastic | Angiogenesis Inhibitors - pharmacology | Gene Expression Profiling - methods | Imidazoles - pharmacology | Transforming Growth Factor beta1 - genetics | Blotting, Western | Fibronectins - metabolism | Breast Neoplasms - metabolism | Breast Neoplasms - genetics | MCF-7 Cells | Breast Neoplasms - pathology | Microarray Analysis | Thrombospondin 1 - genetics | Female | Antineoplastic Agents - pharmacology | Fibronectins - genetics | Thrombospondin 1 - metabolism | Real-Time Polymerase Chain Reaction | Diphosphonates - pharmacology | Fibronectins | Transforming growth factors | Gene expression | Analysis | Cancer cells | Motility | Transforming growth factor | Metastasis | Osteolysis | Cancer therapies | Fibronectin | Metastases | Cell adhesion & migration | Bone resorption | Angiogenesis | Biomedical materials | Actin | Zoledronic acid | Inhibition | Vascular endothelial growth factor | Growth factors | Thrombospondin | Nitrogen | Studies | Molecular modelling | DNA microarrays | Acids | Antiangiogenics | Medical prognosis | Breast | Cytoskeleton | Bone | Tumors | Apoptosis | Original
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 4, pp. 397 - 398
To the Editor: Aprepitant is the first commercially available drug of a new class of neurokinin-1–receptor antagonists for treating chemotherapy-induced nausea... 
PREVENTION | NAUSEA | MEDICINE, GENERAL & INTERNAL | Erlotinib Hydrochloride | Pruritus - drug therapy | Humans | Quinazolines - adverse effects | Adult | Female | Male | Aged | Protein Kinase Inhibitors - adverse effects | Morpholines - therapeutic use | Neurokinin-1 Receptor Antagonists | Pruritus - chemically induced | Cancer therapies | Medical treatment | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 16, pp. 2622 - 2629
Purpose PTEN, AKT, and KRAS are epidermal growth factor receptor (EGFR) downstream regulators. KRAS mutations confer resistance to cetuximab. This... 
CELL LUNG-CANCER | PANITUMUMAB | K-RAS MUTATIONS | THERAPY | GROWTH-FACTOR-RECEPTOR | EFFICACY | ONCOLOGY | SIGNALING PATHWAY | RESISTANCE | EGFR | CHEMOTHERAPY | Immunohistochemistry | Predictive Value of Tests | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | PTEN Phosphohydrolase - analysis | Drug Resistance, Neoplasm | Male | Patient Selection | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Phytogenic - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Retrospective Studies | Cetuximab | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-akt - analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - secondary | Italy - epidemiology | Aged | Mutation | Longitudinal Studies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 638 - 638
Journal Article
Sìlarus: Rassegna Bimestrale di Cultura, ISSN 0037-5179, 2004, Volume 44, Issue 235, p. 83
Journal Article